Heparinase I (neutralase) reversal of systemic anticoagulation

Anesthesiology

Volumn 85, Issue 2, 1996, Pages 339-346

  Michelsen, Luis G ^a   Kikura, Mutsuhito ^a   Levy, Jerrold H ^a   Lee, Mi Kyoung ^a   Lee, King C ^b   Zimmermann, Joseph J ^b   Szlam, Fania ^a  

^a Department of Anesthesiology ^*

^b IBEX Technologies

Author keywords

Blood, anticoagulation: heparin; heparin neutralization; Pharmacology: heparinase; protamine

Indexed keywords

HEPARIN; HEPARIN LYASE; NEUTRALASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; DOG; DOSE RESPONSE; DRUG ANTAGONISM; DRUG SAFETY; EXTRACORPOREAL CIRCULATION; HEPARINIZATION; HUMAN; INTRAOPERATIVE PERIOD; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0029811173     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199608000-00016     Document Type: Article

References (10)

1. Horrow J: Protamine: Areview of its toxicity. Anesth Analg 1985; 64:348-61
2. Levy JH: Anaphylactic Reactions in Anesthesia and Intensive Care: Stoneham, Butterworth-Heinemann, 1992, pp 113-8.
3. Ma X, Mohammad SF, Kim SW: Heparin removal from blood using poly(L-lysine) immobilized hollow fiber. Biotechnol Bioeng 1992; 40:530-536
4. Yang VC, Port FK, Kim JS, Teng CLC, Till GO, Wakefield TW: The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. ANESTHESIOLOGY 1991; 75:288-97
5. Schoen P, Lindhout T, Franssen J, Hemker HC: Low molecular weight heparin-catalyzed inactivation of factor Xa and thrombin by antithrombin III - effect of platelet factor 4. Thromb Haemost 1991; 66:435-41
6. Levy JH, Cormack JG, Morales A: Heparin neutralization by platelet factor 4 and protamine. Anesth Analg 1995; 81:35-7.
7. Hutt ED, Kingdon HS: Use of heparinase to eliminate heparin inhibition in routine coagulation assays. J Lab Clin Med 1972; 79:1027-34
8. Baugh RF, Deemar KA, Zimmermann JJ: Heparinase in the Activated Clotting Time Assay: Monitoring heparin-independent alterations in coagulation function. Anesth Analg 1992; 74:201-5
9. Gravlee GP, Angert KC, Tucker WY, Case LD, Wallenhaupt SL, Cordell AR: Early anticoagulation peak and rapid distribution after intravenous heparin. ANESTHESIOLOGY 1988; 68:126-9
10. Jacques LB: A study of the toxicity of the protamine, salmine. Br J Pharmacol 1949; 4:135-44